DaVita Inc.
Market Cap
$10.36B
P/E Ratio
16.31
EPS
$9.51
Dividend Yield
0.00%
52-Week Range
$101.00 — $159.42
Volume
573.54K
Avg Volume
995.46K
Beta
0.92
Get alerted when DVA hits your target price.
Free — enter your email to get started
P/E (TTM)
16.31
Forward P/E
11.14
PEG Ratio
-1.10
P/S (TTM)
0.74
P/B (TTM)
-20.08
P/FCF
24.75
EV/EBITDA
27.25x
EV/Sales
—
ROE (TTM)
-1.61%
ROA (TTM)
0.04%
ROIC
0.03%
Gross Margin
0.31%
Operating Margin
0.15%
Net Margin
0.07%
Debt/Equity
-23.12
Current Ratio
1.29
EPS Growth (YoY)
-0.21%
Revenue Growth (YoY)
-0.06%
EPS Growth (3Y)
+0.21%
EPS Growth (5Y)
+0.14%
Sales Growth (3Y)
+0.06%
Sales Growth (5Y)
+0.03%
EPS Est (This Year)
$13.92
EPS Est (Next Year)
$16.09
Dividend Yield
—
Annual Dividend
—
Payout Ratio
0.00%
Frequency
—
Ex-Dividend Date
—
Cash/Share
$9.08
Buy
1 = Strong Buy, 5 = Strong Sell
Price Target Range
Consensus Target: $168.67(8.7% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
66.85M
Float
63.19M
Free Float %
94.52%
Sector
Healthcare
Industry
Medical - Care Facilities
Country
US
Exchange
NYSE
IPO Date
1995-10-31
Employees
76000
CEO
Javier J. Rodriguez
Index Membership
S&P 500
Website
https://www.davita.com
DaVita Inc. (DVA) is a healthcare company in the medical - care facilities industry listed on the NYSE. With a market capitalization of $10.36B, a P/E ratio of 16.31, DVA is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare DVA against other stocks using dozens of fundamental and technical filters.
UHS
Universal Health Services, Inc.
$168.27
+0.18%
$10.53B
MMED
MiniMed Group, Inc. Common Stock
$12.34
+2.66%
$3.47B
CHE
Chemed Corporation
$424.98
+0.25%
$5.64B
THC
Tenet Healthcare Corporation
$177.12
-1.65%
$15.52B
FMS
Fresenius Medical Care AG & Co. KGaA
$22.57
+1.85%
$12.61B
SOLV
Solventum Corporation
$67.36
+1.31%
$11.69B
DaVita Inc. (DVA) has a trailing twelve-month (TTM) P/E ratio of 16.31. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, DaVita Inc. (DVA) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
DaVita Inc. (DVA) has a market capitalization of $10.36 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Buy" rating on DaVita Inc. (DVA) with an average score of 2.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $168.67 implies 8.7% upside from the current price.